Vaeksthormonbehandling af korte børn født small for gestational age

TY - JOUR

T1 - Vaeksthormonbehandling af korte børn født small for gestational age

AU - Christesen, Henrik B Thybo

AU - Jensen, Rikke Bodin Beck

AU - Birkebaek, Niels H

AU - Hertel, Niels Thomas

AU - Main, Katharina M

AU - Mortensen, Henrik B

AU - Naeraa, Rune W

AU - Juul, Anders

PY - 2006

Y1 - 2006

N2 - Short children born small for gestational age (SGA) are defined as having a birth weight below -2 SD for gestational age and a reduced height at four years of age (height <-2.5 SD). Growth hormone (GH) treatment significantly improves final height (mean height gain 12 centimetres) in such children. Consequently, GH therapy has been an approved indication in Europe since 2003 for SGA children who remain short at four years of age. The Danish consensus guidelines for diagnosis, treatment and control of short SGA children are described in this review.

AB - Short children born small for gestational age (SGA) are defined as having a birth weight below -2 SD for gestational age and a reduced height at four years of age (height <-2.5 SD). Growth hormone (GH) treatment significantly improves final height (mean height gain 12 centimetres) in such children. Consequently, GH therapy has been an approved indication in Europe since 2003 for SGA children who remain short at four years of age. The Danish consensus guidelines for diagnosis, treatment and control of short SGA children are described in this review.

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 168

SP - 889

EP - 895

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 9

ER -